penicillin are the ready protein linkers. This fact must partly explain the fallibility of both patch and scratch testing; positive results may develop but the results are so equivocal that reliance should not be placed on them. What we need is the means to separate the allergic from the toxic reaction with assurance, and until this becomes available we must guess, albeit with inspiration.
Skin Testing and Desensitization to Drugs by A W Frankland MA DM (London)
Before considering whether information can be obtained of drug sensitivity in a patient by means of skin testing, brief mention must be made of some of the basic immunological problems involved when a patient reacts in some untoward way to a drug. We have always to think in general terms in any allergic reaction whether it is of the 'immediate' or the 'delayed' type. The problem is a complex one because we often do not know the actual 'antigen' that causes the reaction. Even if a low molecular drug has to combine with serum protein to become a hapten, there may have to be many hapten molecules attached to a protein molecule before the molecule develops specific immunological properties. In some cases drugs only sensitize when they are subject to oxidation. Phenothiazine normally causes no trouble, but if allowed to stand and change colour, anyone who touches it develops a dermatitis (Williams 1958) . While there are many difficulties in knowing what antigen causes a reaction, antibodies are particularly difficult to characterize. The immunologists now have many very sensitive techniques to study antibody formation, but unfortunately the antibodies that may occur with a drug reaction are not necessarily directly related to the reaction. Failure to demonstrate antibodies may not mean that they are not there. It has been found that the presence of a tuberculin antibody in the x globulins, can be masked by the y globulins of whole serum.
It seems certain that many cutaneous drug eruptions have no immunological basis but are determined by enzyme interference such as the pellagra dermatitis due to isoniazid (Harrison & Feiwel 1956) or to a genetically determined deficiency such as occurs in favism and primaquine sensitivity.
Patch Testing and Drug Sensitivity Patch testing with offending allergens to prove a specific sensitivity has been in use in England since 1645 (Macalpine & Hunter 1956) . It is often no easy matter to decide whether a positive patch test is a specific allergic response or whether it is quite non-specific, or whether the clinical reaction is truly allergic or not. The patch test aims to be a specific procedure which will reproduce the skin lesion on an uninvolved area of skin. Various textbooks on dermatology will give both the diluting material and the strength of the testing preparation (Schwartz et al. 1957) . There is only general agreement as to the strength of testing material that should be used and often widely different strengths are advised by different authors and there is no agreed standard patch test procedure.
False positive responses are not uncommonly seen in eczematous patients particularly in patients who have an epidermal sensitivity. The threshold of reactivity is particularly inconstant as it is lower in the eczematous patient than the normal and varies according to the phase of the eczema (Wilson 1955) . A nonspecific state of increased sensitivity rather than a true epidermal allergy seems particularly liable to occur during an acute phase of a contact sensitivity. It may be possible to distinguish between a primary irritant and an allergic reaction by retesting after several weeks using dilutions of the test substance. One of the three following patterns may be seen:
(1) The true allergic reactionerythema, cedema and vesicles, the reaction diminishing very gradually as the test substance is diluted. (2) The irritant reactioncausing erythema, oedema and follicular papulesmay become necrotic but fades quickly as the test substance is diluted.
(3) A nonspecific false positiveerythema and cedema appearing with some dilutions and not others.
It may be sometimes very difficult to decide whether a response is a true allergic reaction or an irritant reaction as, in a reactive skin, low concentrations may give a typical positive response.
On retest in a few months this may have become negative. The problem of photosensitization by drugs illustrates some of our difficulties in interpretation of patch testing. Photosensitization is no new problem but the widespread use of chlorproma-zine has brought this problem to the fore. Calnan (1960) has already described some differences in clinical findings as well as the difficulties of patch testing. Sometimes sunlight acts quite nonspecifically in atopic individuals in whom there is no abnormal response to tests for photosensitivity (Stevanovic 1960) . I have seen an elderly woman who was given promethazine by mouth and at the same time promethazine cream for a dermatitis of her hands. She developed a heemorrhagic vesicular eczematous response on her hands and became light sensitive on the exposed parts. While photosensitization can occur with sulphonamides, the latter can also cure the photosensitization that may occur with lymphogranuloma inguinale (Sonck 1960) .
Immediate Whealing Response in Skin Tests
In general we can state that the immediate type wheal response and passive transfer tests for demonstrating Prausnitz-Kiistner antibodies are very rarely of value in finding causal agents in allergic drug reactions. Occasionally drugs will produce an acute immediate anaphylactic type of reaction and sometimes, as in penicillin and sulphonamides, aminophylline and other drugs, an immediate positive skin test will be obtained. It is, however, well to remember that while aspirin is the commonest drug to cause urticaria or quantitatively make it worse, no positive skin or immunological test can be obtained in patients affected by it. One of the reasons for this may be that aspirin, like many other drugs, not only is relatively insoluble but also has a small molecular weight and is unlikely to give rise to reaginic antibodies. To get over this difficulty and to make complex allergens, in Hansen's clinic in Germany (Schwarz 1960 ) the patient's serum (nine parts) was incubated with the drug (one part). This complex, after incubation for one hour, produced positive skin tests with drugs such as amidopyrine, streptomycin, salicylates, and phenobarbitone but not penicillin. However, Rajka (1960) by combining penicillin with y-globulin, was able to obtain positive immediate skin responses in 34 out of 40 cases. He suggests that the antigen under normal circumstances must always be a penicillin-protein combination.
We are in great need of in vitro diagnostic methods for testing in drug allergy. Precipitating antibodies using gel diffusion methods or nephelometric methods in my hands have failed to be of use, or when positive, other easier methods of detection of drug sensitivity have been available.
The commonest cause of urticaria is aspirin, with penicillin probably second. How much information can be obtained from specific skin testing towards these two drugs? Aspirin sensitivity is especially common in that group of patients who 4 have the triad of high blood eosinophilia, nasal polyposis and asthma. There seems no doubt that in these patients the drug sensitivity is based on an allergic mechanism. By 'allergy' we mean that the reaction is based on an antigen-antibody reaction, yet we have no immunological test or any type of skin test to confirm the commonest drug sensitivity. It may well be as Warin (1960) has pointed out, that some patients with urticaria are quantitatively made worse by aspirin. We can presume in these patients that aspirin is not acting specifically as an antigen but in some other nonspecific way. It seems very likely that penicillin, too, can in some way give rise to transient vasodilatation and increased capillary permeability which once established does not need the continuance of an exogenous antigen (Bettley 1960) . For this and other reasons skin tests in possible penicillin sensitivity are confusing and unreliable. As a research project, skin tests in suspected cases of penicillin sensitivity are worth carrying out, but to obtain information from skin testing using penicillin, is unwise. A negative skin test whether patch, intracutaneous or conjunctival does not exclude penicillin sensitivity, while a positive reaction using any of these methods, does not, unfortunately, confirm a diagnosis of penicillin sensitivity. Cross-sensitization may occur in some patients. This may be seen in crosssensitization in 'para' sensitivity (Rajka 1952) . It is, however, this type of patient who has a polysensitivity to many allergens and who also will give irritative reactions on patch testing. It can, therefore, be very difficult to interpret a positive patch test in some patients. A negative patch test also does not exclude a drug reaction because, as already mentioned, sunlight or heat, friction or irritation, may also have to be present. Sometimes a patient becomes sensitive to almost all drugs (Frankland 1958) .
Although it is possible to generalize about methods of patch testing, special mention must be made of neomycin sensitivity. Neomycin is very poorly absorbed from the unbroken skin so that patch testing with this drug is often unrewarding, although sometimes a positive patch test is obtained. It is, therefore, recommended that intracutaneous tests are performed using 0 05 ml of 1 % solution of neomycin sulphate. This will give a specific delayed response in patients sensitive to the drug (Calnan & Sarkany 1958) . Crosssensitivity to streptomycin may occur because of the close chemical relationship between neomycin A and streptidine, a component of streptomycin (Sidi et al. 1957) . Neomycin is often combined with a hydrocortisone base and this may make the clinical picture difficult to evaluate. Moreover, sensitivity to hydrocortisone ointment as well as to the base may occur.
Desensitization to Drugs
In general, drug allergy is like any other allergic sensitivity. The basic principle of treatment is to find the cause and eliminate it. Sometimes, however, desensitization must be undertaken particularly for streptomycin and penicillin in those who give and those who receive these drugs. Socalled penicillin sensitivity may be due to procaine sensitivity. The latter sensitivity may show itself as a simple contact sensitivity or it can cause anaphylactic death (Fernstrom 1960) . Procaine also happens to be a drug showing manifestations of cross-sensitization (group sensitization) to chemically related substances. These include other synthetic local aneasthetics, the sulphonamides and paraphenylenediamine. The incidence of drug reactions in patients undergoing antituberculous treatment is over 10% (Kalinowski 1960) . The commonest drug reaction is that of fever with an irritating morbilliform rash. This rash commonly comes on between the fourth and sixth week of treatment, but it may be sooner or much later. Skin testing is generally completely unreliable and strange to say by giving antihistamine drugs many of the patients seem to grow out of the sensitivity. Sensitivity to PAS and streptomycin may occur together and it may often be advisable to continue streptomycin injections in such patients. It is generally possible, by lowering the dose, completely to desensitize such an induced sensitivity in five to seven days, under cover of steroid treatment. Occasionally, however, it is impossible to desensitize the patient and I had such a patient with tuberculous meningitis who, during the whole period from the time she became sensitized to streptomycin until the end of six months' injection treatment, had to be on continued steroid treatment because of her sensitivity.
Finally, mention should be made of desensitization in those nurses who have developed a contact sensitivity to streptomycin and who want to continue working with streptomycin. Desensitization is hazardous and prolonged (Wilson 1956), but in the few that I have attempted I have not seen failure though I have seen relapse. Such desensitization may take up to two months as an in-patient under steroid cover. The first dose should be 1 tg and gradually increasing doses are given until a dose of 1 g is reached.
